Senores Pharmaceuticals Ltd Half Yearly Results

Gross Sales

274.4

207.89

170.09

181.14

33.38

Excise Duty

0

0

0

0

0

Net Sales

274.4

207.89

170.09

181.14

33.38

Other Operating Income

25.35

9.34

10.93

0

0

Other Income

8.76

16.92

2.34

2.76

0.06

Total Income

308.51

234.15

183.36

183.9

33.44

Total Expenditure

216.07

172.1

136.45

143.6

29.32

PBIDT

92.44

62.05

46.91

40.3

4.12

Interest

11.24

11.46

10.09

5.48

3.97

PBDT

81.2

50.59

36.82

34.82

0.15

Depreciation

14.09

9.43

7.41

6.96

3.06

Minority Interest Before NP

0

0

0

0

0

Tax

16.27

12.83

2.73

8.64

-0.64

Deferred Tax

-0.45

-6.06

2.73

-2.07

-13.69

Reported Profit After Tax

51.29

34.39

23.95

21.29

11.42

Minority Interest After NP

-0.82

-0.62

0.4

-1.75

3

Net Profit after Minority Interest

52.11

35.01

23.55

23.04

8.42

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

52.11

35.01

23.55

23.04

8.42

EPS (Unit Curr.)

11.14

7.6

7.43

7.55

2.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

46.05

46.05

46.05

30.51

29.95

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

33.68

29.84

27.57

22.24

12.34

PBDTM(%)

-

-

-

-

-

PATM(%)

18.69

16.54

14.08

11.75

34.21